Harrow Health Inc. (NASDAQ: HROW) Attends 31st Annual ROTH Conference
Harrow Health (NASDAQ: HROW) (formerly Imprimis Pharmaceuticals, Inc.) owns a portfolio of healthcare businesses, including the nation's leading ophthalmology pharmaceutical compounding business, ImprimisRx. The company holds large equity positions in Eton Pharmaceuticals, Surface Pharmaceuticals, Melt Pharmaceuticals, Mayfield Pharmaceuticals and Radley Pharmaceuticals, companies founded as subsidiaries of Harrow Health. The company also owns royalty rights in certain 505(b)(2) drug candidates being developed by Eton, Surface, Melt, Mayfield and Radley. Harrow intends to create, invest in and grow paradigm shifting health care businesses that put patients first. For more information, visit the company's website at www.harrowinc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a…







